Home

Quest Resource Holding Corporation Reports First Quarter 2022 Financial Results

TW's Take: QRHC continues to grow rapidly and the future looks very bright as indicated by this quote from the CEO, "We expect continued...

INmune Bio Looks to Change The CNS Landscape. An Interview With CEO R.J. Tesi...

Dan Carlson, TW Research (Dan) RJ and CJ, thanks for joining us today. I’d like to start out by saying I find it very interesting...

It’s Still The Early Innings

Two weeks ago this newsletter was titled, "Don't Fight The Fed". That week I discussed why the market was headed lower. The bottom line...

Movano Successfully Completes Functional Testing of Smallest Ever Custom mmWave Sensor Designed for Non-Invasive...

TW's Take: another positive step for Movano as they look poised to become the leaders in non-invasive glucose monitoring.  PLEASANTON, Calif., May 12, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq:...

TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

TW's Take: continued visible progress on their internal programs, and behind the scenes on partnerships, positions TFF for a number of major catalysts over...

INmune Bio, Inc. Presents Data Demonstrating XPro™ Promotes Remyelination in Gray Matter at 3rd...

TW's Take: this is excellent data that demonstrates remyelination in gray matter on top of the white matter data previously presented by IMEKA. XPro...

Stepping on Rakes

Last week was the second week in a row where the TW portfolio was basically unchanged. A sign that markets are calming down? Actually,...

INmune Bio, Inc. Announces First Quarter 2022 Results and Provides Business Update

BOCA RATON, FL., May 05, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness...

Top Global Virtual Reality Gaming Company Chooses Spectra7 Chipset to Power its Next Generation...

TW's Take: very positive news for SPVNF as it opens up a new, fast growing market. Spectra7 is poised for a big 2nd half...

enVVeno Medical Reports First Quarter 2022 Financial Results and Provides Corporate Update

TW's Take: we continue to believe that, trading around 20% below cash on the books, NVNO represents a compelling risk/reward opportunity. The science here...

TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology...

TW's Take: the versatility of thin-film-freezing is set to open up a broad swath of products that will benefit from this technology. Continue to...

Spectra7 Announces Fourth Quarter and Fiscal Year 2021 Financial Results

TW's Take: Spectra7 is setting up for a big second half as demand remains robust and supply should increase dramatically. We wish Raouf a...

The Rolling Correction Gathers Steam…

Thus endeth the worst month for the stock market since March of 2020. Friday's meltdown took the S&P to -9% for the month. It's...

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of...

TW's Take: quite positive that this trial is getting attention from ASCO, the preeminent  cancer meeting. We believe Cleveland Clinic is likely to also...

Atomera Provides First Quarter 2022 Results

LOS GATOS, CA / ACCESSWIRE / April 27, 2022 / Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results...

Atomera Enters into Joint Development Agreement with Major Foundry

TW's Take: further validation sets the stage for Atomera to become a disruptive force in the semiconductor industry over the coming years. LOS GATOS, CA /...

Does Nkarta’s Positive NK Data Have Any Relation To INmune Bio’s INKmune Program?

~ This article is available for premium subscribers only. Please do not share the information here with non-premium subscribers or with company managements. Thank...

Mustang Bio Announces Updated Interim Phase 1/2 Data for MB-106, CD20-Targeted CAR T Therapy,...

TW's Take: solid results from this FBIO partner company. CAR-T doesn't have the cachet it did a couple short years ago, but this program...

It’s A Process

This past week in Charlottesville, The Boar's Head Women's Open took place. This is an annual tennis tournament featuring 32 professional tennis players, most...

CHMP adopts positive opinion for Filsuvez® for the treatment of Dystrophic and Junctional EB

TW's Take: good news for a product that had been basically taken out of Wall Street's models. DUBLIN, Ireland, and Boston MA, April 22, 2022,...

Become a TW Research Member

All our articles are free for everyone to enjoy, however you must register as a user. Please take the time to sign up, it’s free and we do not share your information with anyone.

For those interested in receiving alerts when we buy or sell stocks for our managed accounts, you should consider becoming a premium subscriber. A premium subscription costs $500 per year and subscribers get emails about every transaction taken in our portfolios, including names that have yet to be added to the Tailwinds site.

SIGN ME UP

Receive Our Weekly Newsletter

Every Sunday we recap the market and consolidate the news from our universe. It’s free to subscribe. Just click on the link below.

Newsletter Signup

DFC Advisory Services LLC (dba TW Research Group) is an investment adviser. We are also compensated for publishing information on certain companies. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.